Back to MW MARSHALL WACE, LLP

SAVASAVA
Showing 7 of 17 quarters

Position history for MWMARSHALL WACE, LLP's holdings in FILANA THERAPEUTICS INC

MARSHALL WACE, LLP holds 1.6M shares of SAVA (FILANA THERAPEUTICS INC), worth $1.9M as of 2026-Q2. The position was decreased (-20.6% shares). SAVA represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$1.9M

Current Shares

1.6M

Total Value Change

+$1.9M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.6M
-20.6%
$1.9M0.0%$2.22
0
2026-Q1
Decreased
2M
-4.9%
$3.4M0.0%$2.22
0
2025-Q4
Increased
2.1M
+2.6%
$4.2M0.0%$2.03
27
2025-Q3
Increased
2.1M
+2774.3%
$6M0.0%$3.14
44
2025-Q2
New
71,714
-
$129,8030.0%$1.75
31
2025-Q1
Exited
0
-100.0%
$00.0%$1.65
0
2024-Q4
New
21,093
-
$49,7790.0%$2.40
28

Other major holders of SAVA: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc., GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used